- Home
- MYFW vs BIOA Comparison
MYFW vs BIOA Comparison
Compare MYFW & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- BIOA
- Stock Information
- Founded
- MYFW 2002
- BIOA 2015
- Country
- MYFW United States
- BIOA United States
- Employees
- MYFW N/A
- BIOA N/A
- Industry
- MYFW Major Banks
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- BIOA Health Care
- Exchange
- MYFW Nasdaq
- BIOA Nasdaq
- Market Cap
- MYFW 172.7M
- BIOA 139.1M
- IPO Year
- MYFW 2018
- BIOA 2024
- Fundamental
- Price
- MYFW $18.75
- BIOA $3.87
- Analyst Decision
- MYFW Buy
- BIOA Hold
- Analyst Count
- MYFW 2
- BIOA 4
- Target Price
- MYFW $23.25
- BIOA $5.67
- AVG Volume (30 Days)
- MYFW 27.1K
- BIOA 365.5K
- Earning Date
- MYFW 04-24-2025
- BIOA 05-15-2025
- Dividend Yield
- MYFW N/A
- BIOA N/A
- EPS Growth
- MYFW 61.11
- BIOA N/A
- EPS
- MYFW 0.87
- BIOA N/A
- Revenue
- MYFW $90,071,000.00
- BIOA N/A
- Revenue This Year
- MYFW $17.74
- BIOA N/A
- Revenue Next Year
- MYFW $11.06
- BIOA N/A
- P/E Ratio
- MYFW $21.55
- BIOA N/A
- Revenue Growth
- MYFW 8.92
- BIOA N/A
- 52 Week Low
- MYFW $13.46
- BIOA $2.88
- 52 Week High
- MYFW $22.32
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- MYFW 49.57
- BIOA N/A
- Support Level
- MYFW $17.52
- BIOA N/A
- Resistance Level
- MYFW $19.00
- BIOA N/A
- Average True Range (ATR)
- MYFW 0.91
- BIOA 0.00
- MACD
- MYFW 0.00
- BIOA 0.00
- Stochastic Oscillator
- MYFW 50.83
- BIOA 0.00
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.